WHO ICTRP trial
Modified DLI (related-donor double negative T cells) in the treatment of relapse…
ChiCTR-ONh-16009021 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-ONh-16009021 |
|---|---|
| Public title | Modified DLI (related-donor double negative T cells) in the treatment of relapse after allogeneic hematopoietic stem cell transplantation of myeloid malignancies single clinical research center |
| Scientific title | Modified DLI (related-donor double negative T cells) in the treatment of relapse after allogeneic hematopoietic stem cell transplantation of myeloid malignancies single clinical research center |
| Primary sponsor | Department of Hematology, Anhui Provincial Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | myeloid malignancies |
| Interventions | Case series:related-donor double negative T (DNT) cells |
| Registration date | Aug 13, 2016 |
| Target size | Case series:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: